Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thiamine + biotin is a combination of two water-soluble B vitamins, thiamine (vitamin B1) and biotin (vitamin B7). Thiamine acts as an essential cofactor in carbohydrate metabolism and energy production, playing a critical role in the function of the nervous system. Biotin functions as a coenzyme for carboxylase enzymes involved in fatty acid synthesis, amino acid catabolism, and gluconeogenesis. The combination is used therapeutically to treat or prevent deficiencies of these vitamins due to poor diet, certain illnesses, alcoholism, or increased requirements such as during pregnancy. Notably, high-dose thiamine plus biotin supplementation is the standard treatment for biotin-thiamine-responsive basal ganglia disease (BTRBGD), a rare inherited neurological disorder caused by mutations affecting thiamine transport into cells[2][3][7]. In this context, early administration can be life-saving and may prevent irreversible neurological damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thiamine + biotin.